 CAMBRIDGE, Mass., Sept. 27, 2022 GLOBE NEWSWIRE -- Wave Life Sciences Ltd. Nasdaq: WVE, a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in an analyst-led fireside chat at the Chardans 6th Annual Genetic Medicines Conference in New York City on Tuesday, October 4, 2022, at 3:15 p.m. ET. 